Magnetic Microcarrier-Based Whole Tumor Cell Vaccines for Tumor Prevention and Immunotherapy

This gelatin microcarrier-based vaccine, combined with localized alternating magnetic field-induced hyperthermia, effectively promotes dendritic cell recruitment, enhances immune responses, and effectively inhibits tumor growth.